Skip to main content
Fig. 8 | Clinical Epigenetics

Fig. 8

From: Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel

Fig. 8

Confusion matrix (in percent) of the validation set of FFPE tumor tissues from 20 cancer types. Confusion matrix of the validation set (n = 78) of cancer type prediction using 200 selected probes. The percentages of correctly predicted samples are highlighted in green; misclassification events are highlighted in pink. True histology/predicted histology is respectively listed in rows/columns. ACC Adrenocortical carcinoma, BLCA Bladder urothelial carcinoma, BRCA Breast invasive carcinoma, CESC Cervical squamous cell carcinoma and endocervical adenocarcinoma; CRC Colorectal cancer, HLM Hematolymphoid malignancies, HN/ESCC Head and neck squamous carcinoma and esophageal squamous cell carcinoma, LIHC Liver hepatocellular carcinoma, LUAD Lung adenocarcinoma, LUSC Lung squamous cell carcinoma, MESO Mesothelioma, PAAD Pancreatic adenocarcinoma, PRAD Prostate adenocarcinoma, SKCM Skin cutaneous melanoma, TGCT Testicular germ cell tumors, THCA Thyroid carcinoma, UC Uterine cancer, Upper GI Upper gastrointestinal adenocarcinoma

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us